Abstract
Background: Reactive oxygen species (ROS) play a major role in the pathogenesis of different chronic and degenerative diseases, including atherosclerosis. However, the lack of feasible and reliable methods limits the spread of oxidative stress estimation for routine application in clinical chemistry laboratories. We have recently evaluated the analytical characteristics of an automated test for the measurement of hydroperoxides (HPs) and its performance in determining oxidative stress levels in a general population. In this study we applied this method for the evaluation of oxidative stress in a cohort of patients with coronary artery disease (CAD).
Methods: A total of 69 patients with angiographically verified CAD and 34 age- and sex-matched control subjects were enrolled in the study.
Results: HPs were higher in patients with CAD (p<0.01), significantly increasing with disease severity (p<0.01). HPs were also higher in subjects with diabetes, dyslipidemia or C-reactive protein >1.5mg/L. A significant positive correlation was observed between glucose and HP levels. In a multivariate model, diabetes (odds ratio OR=3.5, 95% CI 1.2–10, p<0.05) and CAD (OR=5.7, CI 1.1–28.5, p<0.05) were independent determinants for the 75th HP percentile.
Conclusions: The results obtained with this method largely reproduce those found using other oxidative stress biomarkers, but the method is faster, easy to perform and does not require skilled operators or complex instrumentation, and thus is a reliable procedure that might represent a feasible tool for oxidative stress estimation in the cardiovascular setting.
Clin Chem Lab Med 2007;45:367–71.
References
1. Kunsch C, Medford RM. Oxidative stress as a regulator of gene expression in the vasculature. Circ Res1999;85:753–66.10.1161/01.RES.85.8.753Search in Google Scholar PubMed
2. Griendling KK, FitzGerald GA. Oxidative stress and cardiovascular injury. Part II: animal and human studies. Circulation2003;108:2034–40.10.1161/01.CIR.0000093661.90582.c4Search in Google Scholar PubMed
3. Locatelli F, Canaud B, Eckardt KU, Stenvinkel P, Wanner C, Zoccali C. Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Nephrol Dial Transplant2003;18:1272–80.10.1093/ndt/gfg074Search in Google Scholar PubMed
4. Iamele L, Fiocchi R, Vernocchi A. Evaluation of an automated spectrophotometric assay for reactive oxygen metabolites in serum. Clin Chem Lab Med2002;40:673–6.10.1515/CCLM.2002.115Search in Google Scholar PubMed
5. Cornelli U, Terranova R, Luca S, Cornelli M, Alberti A. Bioavailability and antioxidant activity of some food supplements in men and women using the D-Roms test as a marker of oxidative stress. J Nutr2001;131:3208–11.10.1093/jn/131.12.3208Search in Google Scholar PubMed
6. Gerardi G, Usberti M, Martini G, Albertini A, Sugherini L, Pompella A, et al. Plasma total antioxidant capacity in hemodialyzed patients and its relationships to other biomarkers of oxidative stress and lipid peroxidation. Clin Chem Lab Med2002;40:104–10.10.1515/CCLM.2002.019Search in Google Scholar PubMed
7. Ridker PM, Brown NJ, Vaughan DE, Harrison DG, Mehta JL. Established and emerging plasma biomarkers in the prediction of first atherothrombotic events. Circulation2004;109:IV6–19.10.1161/01.CIR.0000133444.17867.56Search in Google Scholar PubMed
8. Vassalle C, Boni C, Di Cecco P, Landi P. Elevated hydroperoxide levels as a prognostic predictor of mortality in a cohort of patients with cardiovascular disease. Int J Cardiol2006;110:415–6.10.1016/j.ijcard.2005.08.046Search in Google Scholar PubMed
9. Vassalle C, Boni C, Di Cecco P, Ndreu R, Zucchelli GC. Automation and validation of a fast method for the assessment of in vivo oxidative stress levels. Clin Chem Lab Med2006;44:1372–5.10.1515/CCLM.2006.243Search in Google Scholar PubMed
10. Vassalle C, Botto N, Andreassi MG, Berti S, Biagini A. Evidence for enhanced 8-isoprostane plasma levels, as index of oxidative stress in vivo, in patients with coronary artery disease. Coron Artery Dis2003;14:213–8.10.1097/01.mca.0000063504.13456.c3Search in Google Scholar PubMed
11. Vassalle C, Petrozzi L, Botto N, Andreassi MG, Zucchelli GC. Oxidative stress and its association with coronary artery disease and different atherogenic risk factors. J Intern Med2004;256:308–15.10.1111/j.1365-2796.2004.01373.xSearch in Google Scholar PubMed
12. Griendling KK, FitzGerald GA. Oxidative stress and cardiovascular injury. Part I: basic mechanisms and in vivo monitoring of ROS. Circulation2003;108:1912–6.10.1161/01.CIR.0000093660.86242.BBSearch in Google Scholar PubMed
13. Schwedhelm E, Bartling A, Lenzen H, Tsikas D, Maas R, Brummer J, et al. Urinary iso-prostaglandin F2α as a risk marker in patients with coronary heart disease: a matched case-control study. Circulation2004;109:843–8.10.1161/01.CIR.0000116761.93647.30Search in Google Scholar PubMed
14. Serdar Z, Aslan K, Dirican M, Sarandol E, Yesilbursa D, Serdar A. Lipid and protein oxidation and antioxidant status in patients with angiographically proven coronary artery disease. Clin Biochem2006;39:794–803.10.1016/j.clinbiochem.2006.02.004Search in Google Scholar PubMed
15. Federici M, Lauro R. Review article: diabetes and athero-sclerosis – running on a common road. Aliment Pharmacol Ther2005;22(Suppl 2):11–5.10.1111/j.1365-2036.2005.02617.xSearch in Google Scholar PubMed
16. Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes1999;48:1–9.10.2337/diabetes.48.1.1Search in Google Scholar PubMed
17. Jialal I, Devaraj S, Venugopal SK. Oxidative stress, inflammation, and diabetic vasculopathies: the role of alpha tocopherol therapy. Free Radic Res2002;36:1331–6.10.1080/1071576021000038531Search in Google Scholar PubMed
18. Libby P. Inflammation in atherosclerosis. Nature2002;420:868–74.10.1038/nature01323Search in Google Scholar PubMed
©2007 by Walter de Gruyter Berlin New York
